Loading...
Found 57 ne-neurology trials
A listing of ne-neurology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
Please refer to Table 5 "Objectives and Endpoints" located on page 34 of protocol version 2.0, version date, 13May2025, for a full description of the objectives of this study. Please refer to Table 5 "Objectives and Endpoints" located on page 34 of protocol version 2.0, version date, 13May2025, for a …
This study investigates chronic inflammatory demyelinating polyneuropathy (CIDP).The study evaluates the effects of an investigational medication on the physical functioning of adults with CIDP.Who can participate: Adults aged 18 and older with a body weight of 150 kg or less and a confirmed diagnosis of typical CIDP may participate. Participants …
The purpose of this clinical trial is to compare the benefits and tolerability of three medications that are FDA-approved and used for migraine preventive treatment - atogepant, a newer migraine preventive medication, propranolol, and topiramate, two older migraine preventive medications. This study will provide a head-to-head comparison of the relative …
This study investigates the effects of an investigational medication compared to a placebo in individuals with Parkinson's disease.The study evaluates the safety, effectiveness, and how the body processes the investigational medication. It looks at participants who are already on a stable treatment.Who can participate: Adults with early-stage Parkinson's disease on …
This study investigates chronic inflammatory demyelinating polyneuropathy (CIDP).The study evaluates the effectiveness of an investigational medication compared to standard treatments in managing CIDP.Who can participate: Adults with CIDP on stable IVIg treatment and meeting specific health criteria can participate. Participants must have an INCAT score between 2 and 9 and …
The primary objective is to compare the Minder System with standard of care as a means of assisting in obtaining any of the following actionable events: diagnosis, seizure characterization, surgery evaluation, event classification, paroxysmal events, psychogenic nonepileptic seizures, or treatment effects. The secondary objectives include comparing the time to the …
This is a study to evaluate AB-1009 (IP under study) in adult patients with late-onset pompe disease (LOPD). LOPD is caused by a genetic mutation resulting in a decrease in the GAA enzyme, resulting in the destruction of muscle tissue. AB-1009, administered as a one-time IV dose, is an gene …
Longitudinal study in patients with ALS and healthy controls. The study involves questionnaires, muscle strength assessments, sample collection (CSF + blood), pulmonary testing, and assessment of disease progression. The duration is 2 years with Q4M visits for patients with ALS.
To assess the ability of adalimumab as compared to placebo to reduce or prevent progression of synuclein-related neurodegeneration in persons with idiopathic REM Sleep Behavior Disorder (RBD)
Double-blind, double-dummy study in adults with CIDP. Patients will be randomized to receive either investigational ARGX-117 and IVIG-placebo OR active standard-of-care IVIG and ARGX-117-placebo. Blood/urine collection, patient-reported outcomes, physician efficacy assessments, ECGs, AEs/ConMeds, and suicidality assessments will be performed.
Please choose between Voice or SMS based delivery of verification code
or